Page last updated: 2024-11-04

benzyl alcohol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Benzyl Alcohol: A colorless liquid with a sharp burning taste and slight odor. It is used as a local anesthetic and to reduce pain associated with LIDOCAINE injection. Also, it is used in the manufacture of other benzyl compounds, as a pharmaceutic aid, and in perfumery and flavoring. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hydroxytoluene : Any member of the class of toluenes carrying one or more hydroxy substituents. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

benzyl alcohol : An aromatic alcohol that consists of benzene bearing a single hydroxymethyl substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

aromatic alcohol : Any alcohol in which the alcoholic hydroxy group is attached to a carbon which is itself bonded to an aromatic ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

aromatic primary alcohol : Any primary alcohol in which the alcoholic hydroxy group is attached to a carbon which is itself bonded to an aromatic ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID244
CHEMBL ID720
CHEBI ID17987
SCHEMBL ID147
MeSH IDM0029566

Synonyms (200)

Synonym
BIDD:ER0248
.alpha.-hydroxytoluene
benzenecarbinol
methanol, phenyl-
(hydroxymethyl)benzene
benzal alcohol
wln: q1r
nsc-8044
nci-c06111
phenylmethyl alcohol
nsc8044
.alpha.-toluenol
alpha-toluenol
benzylalkohol
CHEBI:17987 ,
alcool benzylique
alcoholum benzylicum
benzylic alcohol
ulesfia (tn)
benzyl alcohol (jp17/nf/inn)
D00077
benzylicum
ccris 2081
nsc 8044
fema no. 2137
euxyl k 100
alcool benzilico [dcit]
benzyl alcohol [usan:inn:jan]
itch-x
hydroxytoluene
phenylcarbinolum
alcohol bencilico [inn-spanish]
brn 0878307
benzoyl alcohol
phenolcarbinol
einecs 202-859-9
ai3-01680
epa pesticide chemical code 009502
caswell no. 081f
alcoholum benzylicum [inn-latin]
benzyl alcohol (natural)
hsdb 46
alcool benzylique [inn-french]
inchi=1/c7h8o/c8-6-7-4-2-1-3-5-7/h1-5,8h,6h
toluene,alpha-hydroxy
NCGC00091865-01
100-51-6
C03485
hydroxymethylbenzene
aromatic primary alcohol
BENZYL-ALCOHOL ,
aromatic alcohol
benzenemethanol
phenylcarbinol
phenylmethanol
C00556
benzyl alcohol
alpha-hydroxytoluene
benzyl alcohol, >=99%, fcc, fg
benzyl alcohol, natural, >=98%, fg
stratospheres(tm) pl-hms (hydroxymethylstyrene) resin, 50-100 mesh, extent of labeling: 2.0 mmol loading, 1 % cross-linked
MBN ,
benzylalcohol
alcohol, benzyl
benzyl alcohol, anhydrous, 99.8%
benzyl alcohole
3762963D-6C2A-4BFF-AD94-3180E51BCA68
B2378
ins-1519
alcohol,benzyl
alcohol benzylicus
ins no.1519
e-1519 ,
e1519
CHEMBL720
benzyl alcohol (jp15/nf)
BMSE000407
phenyl methanol
AKOS000119907
A800221
NCGC00091865-02
NCGC00091865-04
NCGC00091865-03
HMS3264B16
lkg8494wbh ,
alcohol bencilico
ec 202-859-9
alcool benzilico
benzyl alcohol [inn:jan:nf]
ulesfia
unii-lkg8494wbh
4-06-00-02222 (beilstein handbook reference)
phenyl-methanol
NCGC00254154-01
NCGC00259996-01
tox21_202447
tox21_300044
STL163453
BBL011938
nsc-760098
nsc760098
pharmakon1600-01502555
dtxcid70152
dtxsid5020152 ,
tox21_111172
cas-100-51-6
S4600
66072-40-0
201740-95-6
FT-0622812
phenylmethan-1-ol
alcohol benzylicus [who-ip latin]
benzyl alcohol [mart.]
alcohol,benzyl [vandf]
benzyl alcohol [orange book]
benzyl alcohol [who-ip]
benzalkonium chloride impurity a [ep impurity]
benzyl alcohol [fcc]
benzyl alcohol [fhfi]
benzyl alcohol [vandf]
benzyl alcohol [hsdb]
benzyl alcohol [ii]
benzyl alcohol [ep monograph]
benzyl alcohol [usp-rs]
benzyl alcohol [inn]
benzyl alcohol [who-dd]
benzyl alcohol [jan]
benzyl alcohol [mi]
benzyl alcohol [inci]
benzalcohol
alcoolbenzylique
benzalalcohol
bentalol
DB06770
CCG-213843
methanol benzene
bdbm16418
SCHEMBL147
phch2oh
bn-oh
c6h5ch2oh
benzene-methanol
benzyl alkohol
bnoh
benzenmethanol
HY-B0892
AB01563201_01
mfcd00004599
J-000153
F0001-0019
SR-01000872610-3
sr-01000872610
benzyl alcohol, saj special grade, >=99.0%
benzyl alcohol, analytical standard
benzyl alcohol, tested according to ph.eur.
benzyl alcohol, reagentplus(r), >=99%
benzyl alcohol, puriss., meets analytical specification of ph.??eur., bp, nf, 99-100.5% (gc)
benzyl alcohol, saj first grade, >=98.5%
benzyl alcohol, puriss. p.a., acs reagent, >=99.0% (gc)
benzyl alcohol, united states pharmacopeia (usp) reference standard
benzyl alcohol, acs reagent, >=99.0%
benzyl alcohol, certified reference material, tracecert(r)
sunmorl bk 20
a-toluenol
enzylalcohol
a-hydroxytoluene
tb 13g
benzyl alcohol, usp, 98.0-100.5%
D70182
benzyl alcohol, lr, >=99%
benzyl alcohol, pharmaceutical secondary standard; certified reference material
benzyl alcohol, ar, >=99.5%
benzyl alcohol, european pharmacopoeia (ep) reference standard
benzyl alcohol, p.a., acs reagent, 99.0%
benzyl alcohol, vetec(tm) reagent grade, 98%
hydroxymethyl resin (200-400 mesh)
185532-71-2
benzylalcohol 100 microg/ml in acetonitrile
Q52353
benzyl alcohol (ring-13c6)
A14564
benzyl alcohol (benzenemethanol)
hydroxymethyl resin (100-200 mesh)
HMS3885F10
benzyl alcohol, acs grade
EN300-20016
benzyl-alpha,alpha-d2 alcohol
benzyl alcohol (ep monograph)
alcohol bencilico (inn-spanish)
zilactinearly relief cold sore
protocoxil
benzyl alcohol (ii)
benzyl alcohol (mart.)
alcohol benzilico
benzyl alcohol (usp-rs)
alcool benzylique (inn-french)
phenyl carbinol
usepa/opp pesticide code: 009502
alcoholum benzylicum (inn-latin)
Z104476418

Research Excerpts

Overview

Benzyl alcohol (BnOH) is a natural colorless liquid organic compound that plays an important role in bacteriostatic and anesthetic processes. Benzyl alcohol is a member of the fragrance structural group Aryl Alkyl Alcohols and is a primary alcohol.

ExcerptReferenceRelevance
"Benzyl alcohol is a widely used preservative, solvent and fragrance material. "( Is benzyl alcohol a significant contact sensitizer?
Ballmer-Weber, B; Buhl, T; Dickel, H; Geier, J; Mahler, V; Rieker-Schwienbacher, J; Schubert, S, 2022
)
2.79
"Benzyl alcohol (BnOH) is a natural colorless liquid organic compound that plays an important role in bacteriostatic and anesthetic processes. "( Benzyl alcohol accelerates recovery from Achilles tendon injury, potentially via TGF-β1/Smad2/3 pathway.
Bai, L; Chen, P; You, T; Yuan, S; Zhang, W; Zhang, X, 2020
)
3.44
"Benzyl alcohol (BnOH) is an aromatic alcohol used worldwide as an excipient in foods, cosmetics, household products, and medications. "( Developmental toxicity triggered by benzyl alcohol in the early stage of zebrafish embryos: Cardiovascular defects with inhibited liver formation and degenerated neurogenesis.
Lee, SJ; Manjunatha, B; Sreevidya, B, 2021
)
2.34
"Benzyl alcohol is an excipient used in many drugs as a stabilizer. "( Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias.
Bopst, M; Huang, S; Lu, M; Ottaviani, G; Sun, K; Wu, X; Xie, J, 2015
)
2.14
"Benzyl alcohol was found to be a good co-solvent as it afforded a high coversion and reduced deactivation of the cells."( Asymmetric reduction of a ketone by wet and lyophilized cells of Geotrichum candidum in organic solvents.
Banerjee, UC; Bhattacharyya, MS; Singh, A, 2012
)
1.1
"Benzyl alcohol is a member of the fragrance structural group Aryl Alkyl Alcohols and is a primary alcohol."( Fragrance material review on benzyl alcohol.
Api, AM; Jones, L; Letizia, CS; Scognamiglio, J; Vitale, D, 2012
)
1.39
"Benzyl alcohol is a weak sensitizer found in a wide array of plants and plant products, foods, cosmetics, and medications. "( Benzyl alcohol allergy: importance of patch testing with personal products.
Curry, EJ; Warshaw, EM, 2005
)
3.21
"Benzyl alcohol (BeOH) is a urinary metabolite of toluene, which has been seldom evaluated for biological monitoring of exposure to this popular solvent. "( Benzyl alcohol as a marker of occupational exposure to toluene.
Ikeda, M; Kawai, T; Miyama, Y; Ohashi, F; Sakurai, H; Takada, S; Ukai, H; Yamauchi, T, 2007
)
3.23
"Benzyl alcohol is a better alternative than diphenhydramine as a local anesthetic for lidocaine-allergic patients."( Randomized trial of diphenhydramine versus benzyl alcohol with epinephrine as an alternative to lidocaine local anesthesia.
Bartfield, JM; Jandreau, SW; Raccio-Robak, N, 1998
)
2.01
"Benzyl Alcohol is an aromatic alcohol used in a wide variety of cosmetic formulations as a fragrance component, preservative, solvent, and viscosity-decreasing agent. "( Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate.
Nair, B, 2001
)
2.02

Effects

Benzyl alcohol (BA) has a well-known fluidizing effect on both artificial and cellular membranes. Benzyl alcohol has been used as a local anesthetic for brief superficial skin procedures. Its efficacy for long-term cutaneous anesthesia has not been established.

ExcerptReferenceRelevance
"Benzyl alcohol (BA) has a well-known fluidizing effect on both artificial and cellular membranes. "( Differential ability of cholesterol-enriched and gel phase domains to resist benzyl alcohol-induced fluidization in multilamellar lipid vesicles.
Maula, T; Slotte, JP; Westerlund, B, 2009
)
2.02
"Benzyl alcohol (BA) has a well-known fluidizing effect on both artificial and cellular membranes. "( Differential ability of cholesterol-enriched and gel phase domains to resist benzyl alcohol-induced fluidization in multilamellar lipid vesicles.
Maula, T; Slotte, JP; Westerlund, B, 2009
)
2.02
"Benzyl alcohol has also been recommended as an adjuvant to lidocaine to reduce lidocaine's injection pain."( Benzyl alcohol attenuates the pain of lidocaine injections and prolongs anesthesia.
Howe, NR; Williams, JM, 1994
)
2.45
"Benzyl alcohol has been used as a local anesthetic for brief superficial skin procedures; however, its efficacy for long-term cutaneous anesthesia has not been established. "( Benzyl alcohol as an alternative local anesthetic.
Martin, S; Wilson, L, 1999
)
3.19

Actions

Benzyl alcohol did not inhibit the milk galactosyltransferase incorporated into DMPC or DPPC liposomes but showed a complex effect on the activity of the enzyme incorporated into DSPC vesicles. Benzyl alcohol may also increase the "fluidity" of the lipid bilayer membranes.

ExcerptReferenceRelevance
"Benzyl alcohol did not inhibit the milk galactosyltransferase incorporated into DMPC or DPPC liposomes but showed a complex effect on the activity of the enzyme incorporated into DSPC vesicles, a stimulation of activity at low concentrations followed by an inhibition."( The effect of linoleic acid and benzyl alcohol on the activity of glycosyltransferases of rat liver Golgi membranes and some soluble glycosyltransferases.
Boggs, JM; Mitranic, MM; Moscarello, MA, 1982
)
1.27
"Benzyl alcohol may also increase the "fluidity" of the lipid bilayer membranes."( Effect of the anesthetics benzyl alcohol and chloroform on bilayers made from monolayers.
Latorre, R; Reyes, J, 1979
)
1.28
"Benzyl alcohol had a slower and less inhibitory effect on GTF production by strain Challis."( Glucosyltransferase production by Streptococcus sanguis Challis and comparison with other oral streptococci.
Buchan, RA; Jenkinson, HF, 1990
)
1

Toxicity

Benzyl alcohol at concentrations modestly higher than what is present in commercial Kenalog is toxic to the rabbit eye. The results suggest sex-dependent hepatic alcohol dehydrogenase-substrate competition between benzyl alcohol and ethanol may precipitate adverse metabolic interaction.

ExcerptReferenceRelevance
" The results suggest sex-dependent hepatic alcohol dehydrogenase-substrate competition between benzyl alcohol and ethanol which may precipitate adverse metabolic interaction particularly in the susceptible female subject."( Benzyl alcohol adverse effects in the rat: implications for toxicity as a preservative in parentral injectable solutions.
Messiha, FS, 1991
)
1.94
" Low doses (less than 800 mg/kg) produced minimal toxic effects within an initial 4-h observation period."( Toxicity of benzyl alcohol in adult and neonatal mice.
George, WJ; Gershanik, JJ; Lertora, JJ; McCloskey, SE; White, L, 1986
)
0.65
"Benzyl alcohol at concentrations modestly higher than what is present in commercial Kenalog is toxic to the rabbit eye."( Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits.
Bessho, K; Cheng, L; Davidson, MC; Freeman, WR; Koh, HJ; Morrison, VL, 2006
)
2.03
" Because 1/10 -vTA appeared to be safe for up to 30 minutes of exposure, use of 1/10 dilutions of vehicle-removed TA is suggested to help surgeons visualize prolapsed vitreous during anterior vitrectomy in complicated cataract surgeries."( Triamcinolone acetonide suspension toxicity to corneal endothelial cells.
Chang, YS; Chen, MF; Tseng, SH; Tseng, SY; Wu, CL, 2006
)
0.33
"To evaluate the toxic effects of two triamcinolone acetonide (TA) vehicles on rabbit retina at different volumes."( A moephologic study of retinal toxicity induced by triamcinolone acetonide vehicles in rabbit eyes.
Li, Q; Liu, W; Mo, B; Wang, J; Wang, N; Yang, L; Zeng, H, 2008
)
0.35
" The intensity of the toxic effects of different vehicles may differ."( A moephologic study of retinal toxicity induced by triamcinolone acetonide vehicles in rabbit eyes.
Li, Q; Liu, W; Mo, B; Wang, J; Wang, N; Yang, L; Zeng, H, 2008
)
0.35
"0mg/mL, the concentration in commercial TA suspensions, was toxic within 5min on each assay for both human and rabbit RPE cells."( In vitro benzyl alcohol cytotoxicity: implications for intravitreal use of triamcinolone acetonide.
Chang, YS; Kuo, PY; Tseng, SH; Tseng, SY; Wu, CL, 2008
)
0.76
" The essential oil had a significant toxic effect against early fourth stage larvae of Aedes aegypti L with an LC(50) value of 28."( Immunotoxicity activity of the major essential oil of Filipendula glaberrima against Aedes aegypti L.
Lee, SJ; Moon, HI, 2010
)
0.36
"Benzyl alcohol lotion 5% (BAL 5%) is a non-neurotoxic topical head lice treatment that is safe and effective in children as young as 6 months of age."( The clinical trials supporting benzyl alcohol lotion 5% (Ulesfia): a safe and effective topical treatment for head lice (pediculosis humanus capitis).
Eyerdam, DH; Hiriart, J; Meinking, TL; Mertz-Rivera, K; Paquet, D; Reyna, S; Rivera, HF; Vicaria, M; Villar, ME,
)
1.86
"1 mL (4 or 12 mg) intravitreal injection for human eye were found safe in guinea pig eyes."( Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide.
Chen, H; Cheng, L; Gu, X; Hou, J; Li, G; Li, Y; Luo, L; Qu, J; Shen, H; Zhang, Y, 2012
)
0.38
" Considering its toxic effect and the loss of protection in PHH, BA is not a clinically useful treatment option for APAP overdose patient."( Benzyl alcohol protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes but causes mitochondrial dysfunction and cell death at higher doses.
Du, K; Jaeschke, H; McGill, MR; Xie, Y, 2015
)
1.86
" After reviewing newly available data, it was concluded that benzyl alcohol, benzoic acid and its salts, and benzyl benzoate are safe in the present practices of use and concentration described in this safety assessment."( Safety Assessment of Benzyl Alcohol, Benzoic Acid and its Salts, and Benzyl Benzoate.
Andersen, FA; Belsito, DV; Bergfeld, WF; Hill, RA; Johnson, W; Klaassen, CD; Liebler, DC; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW,
)
0.69
"Some pharmaceutical excipients may cause adverse reactions, excipient-related interactions and/or contraindications."( Pharmaceutical excipients with potential to cause adverse effects in paediatric nasal medicines.
Canji-Panic, JM; Komazec, ZS; Lalic-Popovic, MN; Stjepanovic, AN; Tesic, TZ; Todorovic, NB, 2022
)
0.72

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic parameters were described using a 2-compartment model."( Pharmacokinetics and pharmacodynamics of propofol with or without 2% benzyl alcohol following a single induction dose administered intravenously in cats.
Griffenhagen, GM; Gustafson, DL; Hansen, RJ; Lunghofer, PJ; Mama, KR; Rezende, ML, 2015
)
0.65
" The aim of this study was to determine the pharmacokinetic profiles of BOH and its metabolites benzoic acid and hippuric acid simultaneously in serum to estimate the BOH release out of the depot."( Pharmacokinetics in Elderly Women of Benzyl Alcohol From an Oil Depot.
El Amrani, M; Kalicharan, R; Schot, P; Vromans, H, 2016
)
0.71

Bioavailability

ExcerptReferenceRelevance
"Whether the bioavailability of growth hormone depends on the concentration or formulation of the preparation was evaluated in 18 growth hormone-deficient patients."( Bioavailability of recombinant human growth hormone in different concentrations and formulations.
Christiansen, JS; Hilsted, J; Jensen, SB; Jørgensen, JO; Rasmussen, MH; Rasmussen, UF; Susgaard, S; Vahl, N, 1996
)
0.29
" The absorption rate constant determined by an analysis of the in vivo data was equivalent to that determined in vitro, whereas the evaporation rate constants were related by the inverse ratio of the headspace volumes."( In vivo evaporation rate of benzyl alcohol from human skin.
Kasting, GB; Saiyasombati, P, 2004
)
0.62
" Compound 13f had high potency, selectivity, fast onset, and long duration of action in vitro and was found to have long duration in vivo, low oral bioavailability in the rat, and to be rapidly metabolized."( Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach.
Barrett, VJ; Bevan, NJ; Biggadike, K; Box, PC; Butchers, PR; Coe, DM; Conroy, R; Emmons, A; Ford, AJ; Holmes, DS; Horsley, H; Kerr, F; Li-Kwai-Cheung, AM; Looker, BE; Mann, IS; McLay, IM; Morrison, VS; Mutch, PJ; Procopiou, PA; Smith, CE; Tomlin, P, 2010
)
0.36
" Bioavailability tests showed alkanes and alkenes to be non-bioavailable."( Application of solid-liquid TPPBs to the production of L-phenylacetylcarbinol from benzaldehyde using Candida utilis.
Daugulis, AJ; Khan, TR, 2010
)
0.36
" The absorption rate constant of compounds is found to be related to the logP of the solubilized prodrug."( Fundamental understanding of drug absorption from a parenteral oil depot.
Kalicharan, RW; Schot, P; Vromans, H, 2016
)
0.43
" It is known that the absorption rate differs between these two muscles."( The contribution of the in-vivo fate of an oil depot to drug absorption.
de Rijk, E; Kalicharan, RW; Oussoren, C; Schot, P; Vromans, H, 2017
)
0.46
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

Five different chemometric methods were developed for the simultaneous determination of betamethasone dipropionate (BMD), clotrimazole (CT) and benzyl alcohol (BA) The drug is available in tablet dosage form and parenteral dosage form containing Benzyl alcohol as a preservative.

ExcerptRelevanceReference
"Aspects of the mechanism by which insulin stimulates the membrane glucose transport system were examined by assessing the influence of the bilayer lipid structure on transport stimulation characteristics, and considering the form of the insulin dose-response curve."( Insulin stimulation of adipocyte membrane glucose transport. A graded biologic response insensitive to bilayer lipid disordering.
Hyslop, PA; Kuhn, CE; Sauerheber, RD, 1987
)
0.27
"Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate were studied in male F344 rats and B6C3F1 mice."( Effects of gavage versus dosed feed administration on the toxicokinetics of benzyl acetate in rats and mice.
Abdo, K; Bugge, C; Clark, J; Espinosa, O; Garcia, D; Goehl, TJ; Yuan, JH, 1995
)
0.29
"Simple, sensitive, rapid and selective gas-liquid chromatographic and difference spectrophotometric methods have been described for the determination of benzaldehyde, an oxidation product of benzyl alcohol, in benzyl alcohol intended for use in the manufacture of parenteral dosage forms."( Gas-liquid chromatographic and difference spectrophotometric techniques for the determination of benzaldehyde in benzyl alcohol.
Hewala, II, 1994
)
0.69
" Neither heparin nor nedocromil sodium affected the dose-response curve or the maximum response to Ach."( Protective effect of heparin on immunologically induced tracheal smooth muscle contraction in vitro.
Abraham, MK; Abraham, WM; Ahmed, T, 1996
)
0.29
" For the second pharmacy, mean triamcinolone acetonide dosage was 23."( Triamcinolone acetonide concentration after filtration of the solvent agent.
Derse, M; Jonas, JB; Papoulis, C; Sagstetter, BU; Schmitz-Valckenberg, P; Spandau, UH; Stiefvater, K, 2005
)
0.33
"A new HPLC-RP method has been developed and validated for the simultaneous determination of benzocaine, two preservatives (propylparaben (nipasol) and benzyl alcohol) and degradation products of benzocaine in a semisolid pharmaceutical dosage form (benzocaine gel)."( A new validated method for the simultaneous determination of benzocaine, propylparaben and benzyl alcohol in a bioadhesive gel by HPLC.
García-Montoya, E; Miñarro, M; Orriols, A; Pérez-Lozano, P; Suñé-Negre, JM; Ticó, JR, 2005
)
0.75
" The drug is available in tablet dosage form and parenteral dosage form containing benzyl alcohol as a preservative."( First derivative spectrophotometric determination of granisetron hydrochloride in presence of its hydrolytic products and preservative and application to pharmaceutical preparations.
Bedair, MM; Hewala, II; Shousha, SM, 2013
)
0.61
" Increasing gene dosage of both the dpgA and those of the chaperones further increased functional D-PhgAT yield up to 14400-fold higher than when the dpgA was expressed alone."( Effective enhancement of Pseudomonas stutzeri D-phenylglycine aminotransferase functional expression in Pichia pastoris by co-expressing Escherichia coli GroEL-GroES.
Jariyachawalid, K; Laowanapiban, P; Meevootisom, V; Wiyakrutta, S, 2012
)
0.38
"Five different chemometric methods were developed for the simultaneous determination of betamethasone dipropionate (BMD), clotrimazole (CT) and benzyl alcohol (BA) in their combined dosage form (Lotriderm® cream)."( Full spectrum and selected spectrum based multivariate calibration methods for simultaneous determination of betamethasone dipropionate, clotrimazole and benzyl alcohol: Development, validation and application on commercial dosage form.
Abdelaleem, Ael-B; Darwish, HW; Elzanfaly, ES; Saad, AS, 2016
)
0.83
"Multidose formulations of biotherapeutics, which offer better dosage management and reduced production costs, require the addition of antimicrobial preservatives (APs)."( Correlating the Effects of Antimicrobial Preservatives on Conformational Stability, Aggregation Propensity, and Backbone Flexibility of an IgG1 mAb.
Arora, J; Joshi, SB; Middaugh, CR; Volkin, DB; Weis, DD, 2017
)
0.46
" Furthermore, these [(BenzA)-b-(PCL)-(AuNPs)] based hCS are appended and evidenced as best carrier capsules for nano-medicines with enhanced loading efficacy (~74%) and dosage based prolonged release kinetics."( Self-assembled block copolymer [(BenzA)-b-(PCL)] micelles to orient randomly distributed AuNPs into hollow core-shell morphology and its role as payload for nanomedicines.
Amgoth, C; Dharmapuri, G; Lakavathu, M; Suman Joshi, DSD, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (34 Items)

ItemProcessFrequency
en:open-beauty-factscore-ingredient29
Open Beauty Factscore-ingredient22
Non food productscore-ingredient12
Non alimentairecore-ingredient5
Iced teascore-ingredient2
Tea-based beveragescore-ingredient2
Frozen foodscore-ingredient2
Beveragescore-ingredient2
Productos no alimenticioscore-ingredient2
Non-Food-Produktecore-ingredient2
Meats and their productscore-ingredient1
Body washcore-ingredient1
Frozen dessertscore-ingredient1
Dessertscore-ingredient1
shampuicore-ingredient1
Air freshenercore-ingredient1
Shake proteinecore-ingredient1
Soin capillairecore-ingredient1
Compléments alimentairescore-ingredient1
fr:Cheveuxcore-ingredient1
Frozen meatscore-ingredient1
Meatscore-ingredient1
en:Eau de Parfumcore-ingredient1
Deodorantcore-ingredient1
Vitaminscore-ingredient1
Dietary supplementscore-ingredient1
Produtos não alimentarescore-ingredient1
Aceite de bebecore-ingredient1
pl:Pasta do zębówcore-ingredient1
fr:Savonnettecore-ingredient1
Shampoocore-ingredient1
Mouthwashcore-ingredient1
Bifidus yogurtscore-ingredient1
Non-foodcore-ingredient1

Roles (4)

RoleDescription
solventA liquid that can dissolve other substances (solutes) without any change in their chemical composition.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
fragranceA substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
benzyl alcoholsCompounds containing a phenylmethanol skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (19)

PathwayProteinsCompounds
Hexuronide and Hexuronate Degradation1520
Glycerol Metabolism II2930
Glycerol Metabolism III (sn-Glycero-3-Phosphoethanolamine)3030
Glycerol Metabolism IV (Glycerophosphoglycerol)3030
Glycerol Metabolism V (Glycerophosphoserine)3030
tea aroma glycosidic precursor bioactivation110
amygdalin and prunasin degradation09
salicin biosynthesis012
salicortin biosynthesis017
volatile benzenoid biosynthesis I (ester formation)119
benzoate biosynthesis I (CoA-dependent, u03B2-oxidative)119
volatile esters biosynthesis (during fruit ripening)018
salicortin biosynthesis020
tea aroma glycosidic precursor bioactivation116
tRNA charging2654
amygdalin and prunasin degradation011
toluene degradation VI (anaerobic)1838
toluene degradation to benzoyl-CoA (anaerobic)1319
toluene degradation to benzoate511
toluene degradation IV (aerobic) (via catechol)1625
superpathway of aerobic toluene degradation3847
volatile esters biosynthesis (during fruit ripening)220
Toluene degradation05

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency39.36200.002541.796015,848.9004AID1347395
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.02000.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency33.88740.003041.611522,387.1992AID1159552; AID1159555
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.09630.000229.305416,493.5996AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency28.18380.023723.228263.5986AID588541
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency68.58960.001723.839378.1014AID743083
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency33.49150.000323.4451159.6830AID743066
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency74.97800.000627.21521,122.0200AID651741
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency0.00230.005612.367736.1254AID624032
Cellular tumor antigen p53Homo sapiens (human)Potency30.20220.002319.595674.0614AID651631
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency39.81070.009610.525035.4813AID1479145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)EC50 (µMol)50,000.00000.00112.000910.0000AID1691839
Gamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)EC50 (µMol)50,000.00000.00141.957810.0000AID1691839
Gamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)EC50 (µMol)50,000.00000.00301.65329.8000AID1691839
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Sulfotransferase 1A1 Rattus norvegicus (Norway rat)Km50.00005.00007.571410.0000AID39219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (136)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
post-embryonic developmentGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
adult behaviorGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
signal transductionGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
gamma-aminobutyric acid signaling pathwayGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
synaptic transmission, GABAergicGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
roof of mouth developmentGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
cellular response to histamineGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chloride transmembrane transportGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
inhibitory synapse assemblyGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chemical synaptic transmissionGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
regulation of membrane potentialGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (41)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
GABA receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
protein bindingGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
benzodiazepine receptor activityGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
GABA-gated chloride ion channel activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
identical protein bindingGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chloride channel activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
neurotransmitter receptor activityGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (33)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
GABA receptor complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit alpha-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
axonGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-ergic synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
dendrite membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
postsynapseGamma-aminobutyric acid receptor subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
cytoplasmic vesicle membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
postsynaptic specialization membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
GABA-A receptor complexGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
chloride channel complexGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
neuron projectionGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
synapseGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
transmembrane transporter complexGamma-aminobutyric acid receptor subunit beta-3Homo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (40)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1145366Octanol-water partition coefficient, log P of the compound1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Application of SCAP to drug design. 1. Prediction of octanol-water partition coefficients using solvent-dependent conformational analyses.
AID624612Specific activity of expressed human recombinant UGT1A92000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1080381Nematicidal activity against Bursaphelenchus xylophilus assessed as nematode mortality at 2 mg/mL measured 24 hr post dose by microscopy2008Journal of agricultural and food chemistry, Aug-27, Volume: 56, Issue:16
Nematicidal activity of plant essential oils and components from coriander (Coriandrum sativum), Oriental sweetgum (Liquidambar orientalis), and valerian (Valeriana wallichii) essential oils against pine wood nematode (Bursaphelenchus xylophilus).
AID168703Inhibition of Rana pipiens muscle activity.1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID1090481Antifungal activity against Colletotrichum camelliae assessed as inhibition of mycelial growth at 2000 ug/mL measured after 5 days of cultivation2006Journal of agricultural and food chemistry, May-31, Volume: 54, Issue:11
Antifungal activities of major tea leaf volatile constituents toward Colletorichum camelliae Massea.
AID1090483Antifungal activity against Colletotrichum camelliae assessed as inhibition of mycelial growth at 1000 ug/mL measured after 5 days of cultivation2006Journal of agricultural and food chemistry, May-31, Volume: 54, Issue:11
Antifungal activities of major tea leaf volatile constituents toward Colletorichum camelliae Massea.
AID39220Maximal velocity (Vmax) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID624609Specific activity of expressed human recombinant UGT1A62000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1603230n-Octanol/water partition coefficient, log P of the compound by RP-HPLC analysis2019Bioorganic & medicinal chemistry, 04-15, Volume: 27, Issue:8
Small structural alterations greatly influence the membrane affinity of lipophilic ligands: Membrane interactions of bafilomycin A
AID1090484Antifungal activity against Colletotrichum camelliae assessed as inhibition of mycelial growth at 500 ug/mL measured after 5 days of cultivation2006Journal of agricultural and food chemistry, May-31, Volume: 54, Issue:11
Antifungal activities of major tea leaf volatile constituents toward Colletorichum camelliae Massea.
AID311367Permeability coefficient in human skin2007Bioorganic & medicinal chemistry, Nov-15, Volume: 15, Issue:22
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
AID1090480Antifungal activity against Colletotrichum camelliae assessed as inhibition of mycelial growth measured after 5 days of cultivation2006Journal of agricultural and food chemistry, May-31, Volume: 54, Issue:11
Antifungal activities of major tea leaf volatile constituents toward Colletorichum camelliae Massea.
AID1102450Fungitoxicity against Colletotrichum gloeosporioides assessed as mycelial growth inhibition by poisoned food technique2003Journal of agricultural and food chemistry, Aug-27, Volume: 51, Issue:18
Quantitative structure-fungitoxicity relationships of some monohydric alcohols.
AID1691837Anesthetic activity in Xenopus laevis tadpoles assessed as increase in loss of righting reflex incubated for 30 to 60 mins
AID555340Effect on growth in Staphylococcus aureus MN8 at 0.50 % after 24 hrs (Rvb = 100%)2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID24226Partition coefficient (logP)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.
AID1691865Inhibition of [3H]pTFD-di-iPr-BnOH labelling of GABAA alpha1beta3gamma2L (unknown origin) expressed in Xenopus laevis oocytes assessed as reduction in photoincorporation at beta subunit measured after 30 mins in presence of GABA by liquid scintillation co
AID1090482Antifungal activity against Colletotrichum camelliae assessed as inhibition of mycelial growth at 1500 ug/mL measured after 5 days of cultivation2006Journal of agricultural and food chemistry, May-31, Volume: 54, Issue:11
Antifungal activities of major tea leaf volatile constituents toward Colletorichum camelliae Massea.
AID28957Partition coefficient (logP)2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Rational determination of transfer free energies of small drugs across the water-oil interface.
AID39219Apparent Michaelis constant (Km) against Arylsulfotransferase (AST IV)2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID28956Partition coefficient (logP) (dodecane)2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Rational determination of transfer free energies of small drugs across the water-oil interface.
AID1691861Inhibition of [3H]azietomidate labelling of GABAA alpha1beta3gamma2L (unknown origin) expressed in Xenopus laevis oocytes assessed as reduction in photoincorporation at M236 residues of alpha1 subunit measured after 30 mins in presence of GABA by liquid s
AID1691839Positive allosteric modulation of GABAA alpha1beta3gamma2L in HEK cell plasma membrane assessed as increase in [3H]muscimol binding measured after 10 mins by liquid scintillation counting method
AID555372Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 0.50 % after 24 hrs relative to control2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID229377Ratio of kcat/Km determined for catalytic efficiency in sulfonation against AST IV2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Comparative molecular field analysis of substrates for an aryl sulfotransferase based on catalytic mechanism and protein homology modeling.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1134602Hexane-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID555373Induction of toxin TSST-1 production in Staphylococcus aureus MN8 at 0.10 % after 24 hrs relative to control2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID1691864Inhibition of [3H]R-mTFD-MPAB labelling of GABAA alpha1beta3gamma2L (unknown origin) expressed in Xenopus laevis oocytes assessed as reduction in photoincorporation at M227 residues of beta3 subunit measured after 30 mins in presence of GABA by liquid sci
AID555341Effect on growth in Staphylococcus aureus MN8 at 0.10 % after 24 hrs (Rvb = 100%)2009Antimicrobial agents and chemotherapy, May, Volume: 53, Issue:5
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID13312991-octanol/D2O distribution coefficient, log D of the compound at pH 7.4 by 1H NMR spectroscopic analysis
AID1331301n-Octanol/water partition coefficient, log P of the compound by HPLC method
AID1090485Antifungal activity against Colletotrichum camelliae assessed as inhibition of mycelial growth at 100 ug/mL measured after 5 days of cultivation2006Journal of agricultural and food chemistry, May-31, Volume: 54, Issue:11
Antifungal activities of major tea leaf volatile constituents toward Colletorichum camelliae Massea.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (832)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990140 (16.83)18.7374
1990's150 (18.03)18.2507
2000's248 (29.81)29.6817
2010's240 (28.85)24.3611
2020's54 (6.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 87.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index87.56 (24.57)
Research Supply Index6.81 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index160.45 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (87.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials34 (3.91%)5.53%
Reviews25 (2.87%)6.00%
Case Studies39 (4.48%)4.05%
Observational0 (0.00%)0.25%
Other772 (88.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Single Treatment Pharmacokinetic and Safety Study of Natroba (Spinosad) Topical Suspension 0.9% w/w in Subjects 1 Month to 3 Years 11 Months of Age With an Active Scabies Infestation [NCT05310734]Phase 450 participants (Anticipated)Interventional2022-03-04Recruiting
Are Technicians Showing Bronchial Hyperreactivity Able to Safely Perform Bronchial Provocation Tests? [NCT01937494]13 participants (Actual)Interventional2013-05-31Completed
A Phase 1 Double-Blind, Placebo-Controlled, Single-Center Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intramuscular Administration of a New Oxime, MMB4 DMS Enhanced Formulation (EF) [NCT02018250]Phase 132 participants (Actual)Interventional2012-03-17Completed
Safe Excipient Exposure in Neonates and Small ChildreN - a Retrospective, Descriptive Study Off the Amount of Ethanol, Propylene Glycol, Benzyl Alcohol, Parabens, Acesulfam k, Aspartame, Glycerol, Sorbitol and Polysorbate-80 Exposed to Pediatric Patients [NCT02545712]630 participants (Actual)Observational2016-01-31Active, not recruiting
A Pediatric Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation [NCT02010333]Phase 222 participants (Actual)Interventional2013-04-30Completed
A Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically Under Maximal Use Conditions for the Treatment of Head Lice Infestation. [NCT01907490]Phase 238 participants (Actual)Interventional2013-03-31Completed
Local Anesthesia for Ultrasound Guided Hip Joint Injections: A Double-Blinded Randomized Controlled Trial of Bacteriostatic Saline Versus Buffered Lidocaine [NCT02209272]Phase 468 participants (Actual)Interventional2014-08-31Completed
Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova. [NCT02624843]Phase 3239 participants (Actual)Interventional2015-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT01907490 (4) [back to overview]Number of the Subjects With AEs.
NCT01907490 (4) [back to overview]PK Parameters: AUC(0-8)
NCT01907490 (4) [back to overview]Pk Parameters: Cmax
NCT01907490 (4) [back to overview]PK Parameters: Tmax
NCT02209272 (3) [back to overview]Anesthetic Infiltration Duration
NCT02209272 (3) [back to overview]VAS for Pain Score During Local Anesthesia Infiltration
NCT02209272 (3) [back to overview]VAS for Pain Score During Subsequent Hip Joint Injection (Local Anesthetic Efficacy)
NCT02624843 (1) [back to overview]Number of Participants With Infestation Successfully Eliminated by Active Treatment.

Number of the Subjects With AEs.

Safety and tolerability assessed by AEs. Number of subjects with reporting AEs. (NCT01907490)
Timeframe: 3 months

Interventionparticipants (Number)
Ha44 Gel 0.74% w/w8

[back to top]

PK Parameters: AUC(0-8)

Area under the concentration-time curve of Ha44 (AUC 0-8) (NCT01907490)
Timeframe: 0-8 hours

Interventionng.h/mL (Mean)
HA44 Gel 0.74%447.5

[back to top]

Pk Parameters: Cmax

Maximum concentration of Ha44 (Cmax) (NCT01907490)
Timeframe: 0 to 8 hours

Interventionng/mL (Mean)
HA44 Gel 0.74%141.4

[back to top]

PK Parameters: Tmax

Time to maximum concentration of Ha44 (Tmax) (NCT01907490)
Timeframe: 0-8 hours

Interventionhours (Median)
HA44 Gel 0.74%0.8

[back to top]

Anesthetic Infiltration Duration

Anesthetic infiltration duration will be measured using a timer on the ultrasound machine, with goal administration between 20-40 seconds. (NCT02209272)
Timeframe: baseline

Interventionseconds (Mean)
Bacteriostatic Saline33.3
Buffered Lidocaine32.7

[back to top]

VAS for Pain Score During Local Anesthesia Infiltration

"The Visual Analog Scale (VAS) for Pain is a validated tool used to measure pain. A 100mm horizontal line anchored by no pain (score of 0) and pain as bad as it could be (score of 100)." (NCT02209272)
Timeframe: baseline to 5-10 minutes later -- immediately after local anesthetic injection administration

Interventionscore on a scale (Mean)
Bacteriostatic Saline13.2
Buffered Lidocaine14

[back to top]

VAS for Pain Score During Subsequent Hip Joint Injection (Local Anesthetic Efficacy)

"The Visual Analog Scale (VAS) for Pain is a validated tool used to measure pain. A 100mm horizontal line anchored by no pain (score of 0) and pain as bad as it could be (score of 100)." (NCT02209272)
Timeframe: baseline to 5-10 minutes later -- immediately after hip joint injection

Interventionscore on a scale (Mean)
Bacteriostatic Saline20.7
Buffered Lidocaine15.6

[back to top]

Number of Participants With Infestation Successfully Eliminated by Active Treatment.

Successful elimination of infestation by active treatment [Time frame: 22 + 2 days]. No evidence of active head lice infestation 22 days after enrollment. (NCT02624843)
Timeframe: Study Day 22 +/-2

InterventionParticipants (Count of Participants)
Benzyl Alcohol Lotion 5%59
Ulesfia (Benzyl Alcohol Lotion 5%)57
Vehicle Placebo Lotion 0%6

[back to top]